Adverse Drug Event (ADE) Prevention

National estimates suggest that adverse drug events (ADEs) contribute an additional $3.5 billion to U.S. health care costs.

ADEs are a direct result of drugs used during medical care that produce harmful events, including, but are not limited to, medication errors, adverse drug reactions, allergic reactions and overdoses.

Featured Success Story:
New Opioid Policies

CMS will implement new opioid policies for Medicare drug plans on January 1. The new policies include:

  • Improved safety alerts when patients fill opioid prescriptions at the pharmacy
  • Drug management programs for patients at-risk for misuse or abuse of opioids or other drugs

CMS posted new training materials, including slide decks and tip sheets for:

CMS also recently released an MLN Matters® Article: A Prescriber’s Guide to the New Medicare Part D Opioid Overutilization Policies for 2019. Visit the Reducing Opioid Misuse webpage for more information on CMS’ overall strategy.